page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Nifedipine (Procardia, Adalat, Procardia XL, Adalat CC)

Category:

  • Miscellaneous

Description:

  • Antihypertensive, antianginal (calcium channel blocker)

Indications:

  • Vasospastic (Prinzmetal’s or variant) angina

  • Chronic stable angina

  • Hypertension

Contraindications:

  • Use of sustained-release preparations in patients with severe obstructive coronary artery disease or recent MI

  • Hypertensive emergencies

Precautions:

  • Pregnancy category C; has been used in pregnant women; compatible with breast feeding

Adverse Reactions (Side Effects):

  • CNS: anxiety, asthenia, depression, dizziness, headache, insomnia, somnolence, tremor

  • CV: bradycardia, dysrhythmia, hypotension, palpitations, peripheral edema, syncope, tachycardia

  • GI: abdominal cramps, constipation, diarrhea, flatulence, dry mouth, nausea, vomiting

  • GU: Nocturia, polyuria

  • SKIN: hair loss, pruritus, rash, urticaria

  • MISC: cough, epistaxis, flushing, muscle cramps, nasal congestion, sexual dysfunction, shortness of breath, sweating, tinnitus, weight gain

Dosage:

Administered orally (capsule, sustained release tablet)

  • Adult:   

    • PO 10mg 3 times daily initially, usual range 10-20mg 3 times daily; doses > 120 mg/day are rarely necessary

    • PO XL 30-60mg daily, titration to doses >90 mg/day not recommended

  • Child: 

    • Hypertensive urgencies: 

      • PO 0.25-.5 mg/kg/dose

Special Considerations:

  •  Administer Adalat CC on an empty stomach

  •  Do not crush or chew sustained release dosage formes

  •  Procardia XL tablets may appear in stool, this is no cause for concern

 

 

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

Advertise on this site